Macroprolactinoma in a young man presenting with erectile dysfunction

Seung-Hun Song1, Jinil Lee2, Dong Suk Kim1

  • 1Department of Urology, Fertility Center of CHA Gangnam Medical Center, CHA University College of Medicine, Seoul, Korea.

Insights

Hyperprolactinemia, a condition of high prolactin levels caused by pituitary adenomas, can lead to erectile dysfunction (ED). This case highlights a young man whose primary symptom of ED was linked to a large prolactinoma, also raising fertility concerns.

Area of Science:

  • Endocrinology
  • Urology
  • Reproductive Medicine

Background:

  • Hyperprolactinemia, often caused by pituitary adenomas, is an uncommon cause of erectile dysfunction (ED).
  • The prevalence of clinically apparent prolactinomas ranges from 6-10 to 50 per 100,000 individuals.
  • Existing literature includes limited reports of prolactinoma presenting with ED.

Observation:

  • This report details a rare case of a young male patient presenting with erectile dysfunction as his primary medical complaint.
  • Diagnostic evaluation revealed a large pituitary adenoma secreting prolactin (prolactinoma).

Findings:

  • The patient's erectile dysfunction was directly attributed to hyperprolactinemia stemming from a significant prolactinoma.
  • The case underscores the importance of considering endocrine causes for ED, even in young individuals.

Implications:

  • This case emphasizes the need for comprehensive diagnostic workups in patients with ED, including hormonal assessments.
  • Management of prolactinomas requires addressing both the tumor and its associated symptoms, such as ED and potential fertility issues.
  • Further research into the link between pituitary adenomas, hyperprolactinemia, and male reproductive health is warranted.

Related Concept Videos

Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
3.9K
Male Sexual Response: Erection & Ejaculation01:17

Male Sexual Response: Erection & Ejaculation

Sexual stimulation can take various forms, such as physical touch and visual or auditory cues. When this happens, the parasympathetic reflex in the sacral portion of the spinal cord is activated. This reflex stimulates the release of nitric oxide (NO), which then dilates the arterioles in the penis, increasing blood flow to the erectile tissues - the corpora cavernosa and corpus spongiosum.
The blood filling the erectile tissues compresses the veins, which helps to prevent blood from leaving...
16.8K
Infertility in Males01:23

Infertility in Males

Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
497
Menopause01:28

Menopause

Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
3.5K
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors01:28

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
500
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
905